» Articles » PMID: 22912892

Additive Mixture Effects of Estrogenic Chemicals in Human Cell-based Assays Can Be Influenced by Inclusion of Chemicals with Differing Effect Profiles

Overview
Journal PLoS One
Date 2012 Aug 23
PMID 22912892
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

A growing body of experimental evidence indicates that the in vitro effects of mixtures of estrogenic chemicals can be well predicted from the estrogenicity of their components by the concentration addition (CA) concept. However, some studies have observed small deviations from CA. Factors affecting the presence or observation of deviations could include: the type of chemical tested; number of mixture components; mixture design; and assay choice. We designed mixture experiments that address these factors, using mixtures with high numbers of components, chemicals from diverse chemical groups, assays with different in vitro endpoints and different mixture designs and ratios. Firstly, the effects of mixtures composed of up to 17 estrogenic chemicals were examined using estrogenicity assays with reporter-gene (ERLUX) and cell proliferation (ESCREEN) endpoints. Two mixture designs were used: 1) a 'balanced' design with components present in proportion to a common effect concentration (e.g. an EC(10)) and 2) a 'non-balanced' design with components in proportion to potential human tissue concentrations. Secondly, the individual and simultaneous ability of 16 potential modulator chemicals (each with minimal estrogenicity) to influence the assay outcome produced by a reference mixture of estrogenic chemicals was examined. Test chemicals included plasticizers, phthalates, metals, PCBs, phytoestrogens, PAHs, heterocyclic amines, antioxidants, UV filters, musks, PBDEs and parabens. In all the scenarios tested, the CA concept provided a good prediction of mixture effects. Modulation studies revealed that chemicals possessing minimal estrogenicity themselves could reduce (negatively modulate) the effect of a mixture of estrogenic chemicals. Whether the type of modulation we observed occurs in practice most likely depends on the chemical concentrations involved, and better information is required on likely human tissue concentrations of estrogens and of potential modulators. Successful prediction of the effects of diverse chemical combinations might be more likely if chemical profiling included consideration of effect modulation.

Citing Articles

The effects of co-exposure to methyl paraben and dibutyl phthalate on cell line derived from human skin.

Miranowicz-Dzierzawska K, Zapor L, Skowron J, Chojnacka-Puchta L, Sawicka D Toxicol Res. 2023; 39(1):71-89.

PMID: 36721678 PMC: 9839924. DOI: 10.1007/s43188-022-00151-3.


Hormonal activity in commonly used Black hair care products: evaluating hormone disruption as a plausible contribution to health disparities.

James-Todd T, Connolly L, Preston E, Quinn M, Plotan M, Xie Y J Expo Sci Environ Epidemiol. 2021; 31(3):476-486.

PMID: 33958708 PMC: 8812815. DOI: 10.1038/s41370-021-00335-3.


Metabolites of n-Butylparaben and iso-Butylparaben Exhibit Estrogenic Properties in MCF-7 and T47D Human Breast Cancer Cell Lines.

Gonzalez T, Moos R, Gersch C, Johnson M, Richardson R, Koch H Toxicol Sci. 2018; 164(1):50-59.

PMID: 29945225 PMC: 6016648. DOI: 10.1093/toxsci/kfy063.


An Investigation of the Single and Combined Phthalate Metabolite Effects on Human Chorionic Gonadotropin Expression in Placental Cells.

Adibi J, Zhao Y, Zhan L, Kapidzic M, Larocque N, Koistinen H Environ Health Perspect. 2017; 125(10):107010.

PMID: 29089286 PMC: 5933420. DOI: 10.1289/EHP1539.


Editor's Highlight: Transcriptome Profiling Reveals Bisphenol A Alternatives Activate Estrogen Receptor Alpha in Human Breast Cancer Cells.

Mesnage R, Phedonos A, Arno M, Balu S, Corton J, Antoniou M Toxicol Sci. 2017; 158(2):431-443.

PMID: 28591870 PMC: 5837682. DOI: 10.1093/toxsci/kfx101.


References
1.
Li J, Yu H, Zhao Y, Zhang G, Wu Y . Levels of polybrominated diphenyl ethers (PBDEs) in breast milk from Beijing, China. Chemosphere. 2008; 73(2):182-6. DOI: 10.1016/j.chemosphere.2008.05.019. View

2.
Smeets J, van Holsteijn I, Giesy J, van den Berg M . The anti-estrogenicity of Ah receptor agonists in carp (Cyprinus carpio) hepatocytes. Toxicol Sci. 2000; 52(2):178-88. DOI: 10.1093/toxsci/52.2.178. View

3.
Kortenkamp A . Ten years of mixing cocktails: a review of combination effects of endocrine-disrupting chemicals. Environ Health Perspect. 2008; 115 Suppl 1:98-105. PMC: 2174407. DOI: 10.1289/ehp.9357. View

4.
Ali I, Penttinen-Damdimopoulou P, Makela S, Berglund M, Stenius U, Akesson A . Estrogen-like effects of cadmium in vivo do not appear to be mediated via the classical estrogen receptor transcriptional pathway. Environ Health Perspect. 2010; 118(10):1389-94. PMC: 2957917. DOI: 10.1289/ehp.1001967. View

5.
Ermler S, Scholze M, Kortenkamp A . The suitability of concentration addition for predicting the effects of multi-component mixtures of up to 17 anti-androgens with varied structural features in an in vitro AR antagonist assay. Toxicol Appl Pharmacol. 2011; 257(2):189-97. DOI: 10.1016/j.taap.2011.09.005. View